Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PB127 Safety and Familiarization in Suspected CAD
NCT00594698Phase 3Completed
- Sponsor
- POINT Biomedical
- Start
- Feb 2002
- Primary completion
- Sep 2003
- Modality
- Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of PB127 in coronary artery disease (CAD), sponsored by POINT Biomedical. Started Feb 2002; status: completed.
02
Drugs
PB127
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00594698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594698.